{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:17:58Z","timestamp":1793755078502,"version":"4.6.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal de Mycologie M\u00e9dicale"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.mycmed.2015.12.002","type":"journal-article","created":{"date-parts":[[2016,2,4]],"date-time":"2016-02-04T00:16:35Z","timestamp":1454544995000},"page":"17-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["In vitro antifungal susceptibility of clinical species belonging to Aspergillus genus and Rhizopus oryzae"],"prefix":"10.1016","volume":"26","author":[{"given":"R.","family":"Kachuei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Khodavaisy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rezaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sharifynia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mycmed.2015.12.002_bib0125","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1086\/319985","article-title":"Invasive mold infections in allogeneic bone marrow transplant recipients","volume":"32","author":"Baddley","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2015.12.002_bib0130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3114\/sim.2007.59.05","article-title":"Aspergillus species identification in the clinical setting","volume":"59","author":"Balajee","year":"2007","journal-title":"Stud Mycol"},{"key":"10.1016\/j.mycmed.2015.12.002_bib0135","series-title":"Antifungal susceptibility tests of Aspergillus species. Aspergillosis: from diagnosis to prevention","first-page":"193","author":"Colombo","year":"2010"},{"key":"10.1016\/j.mycmed.2015.12.002_bib0140","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/jac\/dkg020","article-title":"In vitro susceptibilities of zygomycetes to conventional and new antifungals","volume":"51","author":"Dannaoui","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2015.12.002_bib0145","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1086\/317487","article-title":"Burden of aspergillosis-related hospitalizations in the United States","volume":"31","author":"Dasbach","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2015.12.002_bib0150","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1128\/JCM.41.8.3623-3626.2003","article-title":"Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi","volume":"41","author":"Diekema","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2015.12.002_bib0155","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1128\/JCM.36.1.198-202.1998","article-title":"In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens","volume":"36","author":"Espinel-Ingroff","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2015.12.002_bib0160","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0196-4399(01)80005-2","article-title":"Clinical relevance of fungal susceptibility testing and antifungal resistance","volume":"22","author":"Espinel-Ingroff","year":"2000","journal-title":"Clin Microbiol Newsl"},{"key":"10.1016\/j.mycmed.2015.12.002_bib0165","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1128\/AAC.01902-12","article-title":"In vitro antifungal susceptibility of clinically relevant species belonging to Aspergillus section Flavi","volume":"57","author":"Gon\u00e7alves","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2015.12.002_bib0245","first-page":"99","article-title":"A review on invasive aspergillosis in patients admitted to intensive care unit with emphasis on diagnostic methods","volume":"20","author":"Hedayati","year":"2009","journal-title":"JMUMS"},{"key":"10.1016\/j.mycmed.2015.12.002_bib0250","doi-asserted-by":"crossref","first-page":"52","DOI":"10.14712\/18059694.2014.24","article-title":"Invasive aspergillosis in intensive care unit patients in Iran","volume":"56","author":"Hedayati","year":"2013","journal-title":"Acta Medica (Hradec Kralove)"},{"key":"10.1016\/j.mycmed.2015.12.002_bib0175","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/jac\/42.6.741","article-title":"In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi","volume":"42","author":"Johnson","year":"1998","journal-title":"J Antimicrobl Chemother"},{"key":"10.1016\/j.mycmed.2015.12.002_bib0180","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/BF03178344","article-title":"Investigation of stored mycoflora, reporting the Fusarium cf. langsethiae in three provinces of Iran during 2007","volume":"59","author":"Kachuei","year":"2009","journal-title":"Ann Microbiol"},{"key":"10.1016\/j.mycmed.2015.12.002_bib0185","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijantimicag.2004.11.010","article-title":"In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study","volume":"25","author":"Mallie","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.mycmed.2015.12.002_bib0190","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/02681219880000361","article-title":"In vitro activity of voriconazole against selected fungi","volume":"36","author":"McGinnis","year":"1998","journal-title":"Med Mycol"},{"key":"10.1016\/j.mycmed.2015.12.002_bib0195","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s12281-008-0012-4","article-title":"Treatment options in emerging mold infections","volume":"2","author":"Mu\u00f1oz","year":"2008","journal-title":"Curr Fungal Infect Rep"},{"key":"10.1016\/j.mycmed.2015.12.002_bib0200","first-page":"371","article-title":"Successful early voriconazole treatment of Aspergillus infection in two non immunocompromised patients in Intensive Care Unit","volume":"73","author":"Nataloni","year":"2007","journal-title":"Minerva Anestesiol"},{"key":"10.1016\/j.mycmed.2015.12.002_bib0205","first-page":"429","article-title":"Antifungal susceptibility of the Aspergillus species by Etest and CLSI reference methods","volume":"15","author":"Parisa","year":"2012","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.mycmed.2015.12.002_bib0210","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and clinical manifestations of mucormycosis","volume":"54","author":"Petrikkos","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2015.12.002_bib0215","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1128\/AAC.46.4.1032-1037.2002","volume":"46","author":"Pfaller","year":"2002","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.mycmed.2015.12.002_bib0225","series-title":"Reference method for broth dlution antifungal susceptibility testing of filamentous fungi. Approved Standard M38-A2","year":"2008"},{"key":"10.1016\/j.mycmed.2015.12.002_bib0230","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00277-007-0292-8","article-title":"Successful treatment with voriconazole of Aspergillus meningitis in a patient with acute myeloid leukemia","volume":"86","author":"Saitoh","year":"2007","journal-title":"Ann Hematol"},{"key":"10.1016\/j.mycmed.2015.12.002_bib0235","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1128\/AAC.00571-13","article-title":"Hyperthermia sensitizes Rhizopus oryzae to posaconazole and itraconazole action through apoptosis","volume":"57","author":"Shirazi","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2015.12.002_bib0240","first-page":"119","article-title":"Antifungal drug resistance in pathogenic fungi","volume":"36","author":"Vanden","year":"1997","journal-title":"Med Mycol"}],"container-title":["Journal de Mycologie M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523315002371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523315002371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:16:12Z","timestamp":1761110172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523315002371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1156523315002371"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2015.12.002","relation":{},"ISSN":["1156-5233"],"issn-type":[{"value":"1156-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro antifungal susceptibility of clinical species belonging to Aspergillus genus and Rhizopus oryzae","name":"articletitle","label":"Article Title"},{"value":"Journal de Mycologie M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2015.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}